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Acute Myocardial Infarction
877-STEMI-SC or 877-783-6472
Adult Critical Care Intensivists
320-309-8132
Behavioral Health Access Nurse
320-255-5774
Hospitalist Program 320-290-8933
CentraCare Clinic Specialties
Allergy 320-654-3650
Bariatric Medicine 320-240-2828
Cardiology & Cardiac Surgery
320-656-7020
Dermatology 320-229-4924
Endocrinology 320-229-5000
Gastroenterology 320-229-4916
Genetic Services 320-654-3654
Infectious Disease 320-240-2204
Internal Medicine 320-240-2203
or 320-229-4928
Maternal & Fetal Medicine 
320-656-7024
Neonatology 320-255-5781
Nephrology 320-240-2206
Neurology 320-240-2829
Neurosurgery 320-240-2836
Obstetrics & Gynecology
320-654-3630
Oncology/Hematology
320-229-4907
Pediatric Critical Care 320-255-5781
Pediatrics 320-654-3610
Pulmonology 320-240-2207
Radiation Oncology 320-229-4901
Rheumatology 320-240-2208
Sleep Medicine 320-251-0726
Sports Medicine 320-229-4917
Surgery 320-252-3342
Wound Care 320-656-7100
Physician Referral Line
320-240-2201 
800-458-7272
St. Cloud Hospital
Patient Transfer Line 
(888) 387-2862
A publication from CentraCare Clinic 
for health care providers in Central Minnesota
I recently heard two speakers talk about health care reform. 
Each had very different perspectives on the federal approach to 
health care reform known as Obamacare or Affordable Care Act. 
Interestingly, both believed that health care reform was needed, and 
each was convinced if their version didn’t move forward, the country 
likely would see major turmoil in the coming years. 
While their versions differed, what was clear is that delivery of health 
care will need to change from the traditional method of fee per service 
to a “value approach.” Understanding what value is and delivering on it 
will be necessary regardless of the rhetoric coming out of Washington.
What is value? First, patients perceive value as the interaction and
service they get from their health care provider. To many patients, quality
is defined by their patient experience. If we don’t deliver on the experience,
there is no value to the patients. Second, rapid communication of clinical
patient information is critical for improving the overall quality of care.
While most providers do react appropriately if they have all the
information, we all have experienced the frustration of trying to manage
a patient while not knowing what a specialist prescribed the day before
or the MRI result completed in another institution a few days ago. 
That information needs to be available instantaneously, just like credit
card purchases that show up online a few minutes after we purchase
something. We, as a profession, need to have the attitude that our work
isn’t done until we appropriately communicate what we did during 
a patient visit. Third, we need to understand what clinical activities
provide value and what is unnecessary or frankly, unhelpful. 
President’s Message
Value is based on the 
patient experience
By David Tilstra, MD 
President, CentraCare Clinic
continued on page 2
Seasonal flu and  
our role as health
care providers
By George Morris, MD, 
Medical Director,
CentraCare Clinic
Influenza (flu) is poised and ready to reemerge to affect 
our patients and us. We know there are only a few things 
we can do to decrease the spread. Good hand hygiene and
immunization are two of the most effective measures. 
The Centers for Disease Control and Prevention (CDC)
estimates that 5 to 20 percent of Americans come down 
with the flu during each flu season. Children are two to three
times more likely than adults to get sick with the flu, and
children frequently spread the virus to others. Although 
most people recover from the illness, the CDC estimates 
that in the United States more than 200,000 people are
hospitalized and about 36,000 people die from the flu 
and its complications every year.
We know that flu can be passed even before a person knows
they are sick, and most people are sick for at least a week. 
To avoid spreading the flu, the CDC recommends that ill
people stay home for at least 24 hours after a fever is gone. 
We encourage all of our providers and staff to receive the
influenza immunization each season. Most companies now
produce quadrivalent vaccines to improve coverage of
multiple strains. Last year’s vaccine effectiveness was about
56 percent when measured as a percentage of individuals 
who saw a provider within seven days of becoming ill. 
We realize this is not a great success rate, but immunization
has shown effectiveness in decreasing time lost from work,
hospitalizations, serious illness and death. One study showed
one life saved per 4,000 immunizations. CentraCare Health’s
goal is to obtain close to 100 percent immunization rate of
our providers and staff. We cannot completely prevent our
patients from becoming ill, but vaccination is one thing 
we can do to protect our patients and us.
If not for YOU,
get the flu vaccine for THEM.
President’s Message 
It’s more than just cutting back on what we do or
looking for the cheapest drugs, tests or materials.
If cutting back on regular HgbA1cs results in a
hospitalization for uncontrolled diabetes, we
haven’t saved any money. We need to continue 
to evaluate what we do to better understand what
provides value to the patient. 
This list can go on, and I am sure many of you could
name more ways to provide value to the patient.
As a profession that is under pressure to change
our mode of health care delivery, we need to focus
now more than ever on putting the patient first.
continued from cover
Rheumatology update
Our Rheumatology department has temporarily
closed its practice to any new consultations or new
visits until further notice. This is because three of
our five rheumatologists have departed for essentially
unrelated reasons in the past six months.
Rheumatologists Aaron Holmgren, MD, and
Bharath Akkara Veetil, MBBS, are committed to
the challenging task of managing our established
patients, many who are taking immuno-modulating
drugs requiring rheumatologic management.
This closure will impact patients who have been
seen in the past, but have not required active
follow-up. Similarly, we are unable to
accommodate new patients who have been seen at
St. Cloud Hospital, even if seen by rheumatology
within the hospital. These patients will be asked to
follow-up with their primary care provider.
We understand and apologize for the burden this
restriction places on our local and regional medical
communities, especially given the relative scarcity
of rheumatology services. Please know we are fully
engaged in an effort to recruit new providers to our
practice and to extend our services by other means. 
In the interim, rheumatology services are available
in Brainerd, Maple Grove, the Twin Cities, Duluth,
Fargo, N.D. and Sioux Falls, S.D. Our staff can help
answer questions that you or your patients may have. 
It is our sincere hope to reopen our practice as soon
as possible so we again can provide new patient
consultations in the St. Cloud area. Until that time,
we thank you for your understanding and support.
While all of us are aware of the transluminal intervention
within the arterial system, the potential and spectrum of
transvenous interventional neurological techniques is less
well understood. Transvenous interventional procedures are
performed via catheters that are introduced through the
femoral vein and advanced through the iliac vein, inferior
vena cava, right atrium, superior vena cava, brachiocephalic
vein and subsequently the internal jugular vein. Microcatheters,
angioplasty balloons, and stents can be further introduced
into the cerebral dural venous sinuses including sigmoid,
transverse, superior sagittal, and other sinuses. Several
procedures can be performed as outlined below:
1. Evaluation of pituitary tumors and Cushing’s disease:
Venous blood sampling via catheterization of petrosal 
veins bilaterally can allow measurement of various 
hormones secreted by both lobes of pituitary glands 
at baseline and after injection of dexamethasone. The 
functional activity assessment allows determination of 
concentration and laterality of hormone secretions. 
The test is the gold-standard method for diagnosing 
Cushing’s disease.
2. Treatment of 
idiopathic 
intracranial 
hypertension:
A prominent 
proportion of 
patients who 
present with 
headaches and 
papilledema 
secondary to 
idiopathic 
intracranial 
hypertension 
have impaired 
venous outflow 
due to stenosis or occlusion of transverse or sigmoid 
sinuses. Treatment of outflow obstruction improves 
venous drainage and pressure with subsequent 
improvement in intracranial pressure (see Figure 1).
3. Treatment of tinnitus: Tinnitus can be secondary to 
enlargement of veins that connect sigmoid sinus to 
external jugular veins. These veins are located behind 
the ear and increased flow creates refractory tinnitus 
(see Figure 2 on next page). The external carotid artery 
branches can anastomose with sigmoid or transverse 
sinuses creating refractory tinnitus through flow via 
these anastomic channels. Obliteration of these 
abnormal channels through coils or liquid embolic 
agents can result in complete cure of symptoms.
4. Treatment of intracerebral hemorrhage:
Increase in venous pressure due to 
thrombosis of the cerebral veins or sinuses 
can result in intracerebral hemorrhages. 
Lysis of thrombus using transvenous 
thrombolytics or mechanical thrombectomy 
can prevent further intraparenchymal hemorrhages 
and intracranial hypertension. Intracerebral hemorrhage 
also can occur because of increase in venous pressure 
secondary to arteriovenous fistulas derived from external 
or internal carotid artery branches pathologically 
anastomosing with sigmoid or transverse sinuses. 
Obliteration of these abnormal channels through coils 
or liquid embolic agents can result in further progression 
of symptoms or new intracerebral hemorrhages.
5. Treatment of multiple sclerosis: Recent studies have 
documented that venous engorgement and perivenular 
inflammation can be seen in patients with multiple 
sclerosis. Impairment of venous outflow due to stenosis 
or occlusion of transverse or sigmoid sinuses can be seen 
in these patients.
Most patients with
multiple sclerosis 
are not candidates
for transvenous
treatment of venous
outflow impairment.
Selection of
appropriate
candidates requires
demonstration of
stenosis or occlusion
of transverse or
sigmoid sinuses 
and increased blood
volumes in cerebral
veins. Transvenous
approach is not 
a cure, but may result in improvement of symptoms in 
a highly select group of patients. 
6. Electroencephalographic monitoring for difficult 
to diagnose seizures: This technique is in early phase of 
evolution. Microwires placed in transverse or straight 
sinus can conduct electrical impulses from brain tissue 
located in the vicinity of the sinuses. Such areas are 
not assessed appropriately by surface electrodes and 
transvenous approach may provide an alternate method 
for electroencephalographic monitoring.
Transvenous interventional neurological techniques
By Adnan Qureshi, MBBS, interventional neurologist, CentraCare Clinic
continued on next page
Figure 1: Venography before and after primary angioplasty of the left transverse 
and sigmoid sinus in a patient with idiopathic intracranial hypertension. Note the
improved flow through left transverse venous sinus after angioplasty (arrows). 
Since the recent cigarette cost increase, a common topic 
for patients has been the role of e-cigarettes in smoking
cessation. The electronic cigarette, or e-cigarette, is a
simple, battery-operated device that heats up liquid nicotine
to create a vapor that a person inhales and then exhales.
This mimics the action of smoking and nicotine is delivered
to the user’s lungs and into the blood stream. E-cigarettes
were first developed in China in the early 2000s and have
been in the United States since about 2007. Many see 
e-cigarette use as a “healthier” alternative to cigarettes since
there is no smoke and just nicotine vapor. But is this true?
There are several concerning issues with e-cigarette use.
The FDA is trying to ban e-cigarettes for use until adequate
research can be conducted to assess safety. Granted, 
the main chemicals in the devices — nicotine, glycol
(which makes the smoke appearance) and flavoring — 
have minimal to no health effects when compared to
cigarettes, but without adequate testing the facts remain
unknown. Also, lack of federal or legal regulations on
product manufacturing creates concern about what 
additives may be included in the device without consumer
knowledge, as well as what health effects could arise. 
The most recent FDA investigation did show traces of
carcinogenic (cancer-causing) chemicals in the e-cigarette,
but the level was nowhere near the amount of cancer-causing
chemicals in cigarettes. The FDA is pushing for more
research on these devices before suggesting use due 
to the lack of evidence to support safe usage.
The other major issue with the e-cigarette 
is more on a social level and has to deal with 
the fact that e-cigarettes contain no tobacco. 
One might say that no tobacco is a good thing,
but this means that e-cigarettes are not subject
to tobacco laws so a minor can purchase the product without
an ID. Although nicotine may not have “adverse” health risks,
it is a very highly addictive drug minors can obtain easily. 
While most consumers may be unaware about the lack of
safety evidence, Canada, Australia, Mexico and Israel have
banned e-cigarettes from sale or usage. Also, Hennepin
County recently banned e-cigarette use on any Hennepin
County-owned property. In addition, Metro Transit also is 
in the process of banning these products on trains and buses
until further research is conducted to assess not only its
safety to the user, but also with second-hand exposure.
From a medical standpoint, it is very difficult for providers to
make an informed judgment on the safety of this product due
to the lack of evidence. With that said, it seems reasonable that
use of these products for smoking cessation may be beneficial,
but it also must be understood they have not been studied to
even show any effectiveness in smoking cessation. 
In my opinion, there are other proven and safe alternatives to
smoking cessation, such as the FDA-approved nicotrol inhaler,
and until further evidence is available, providers should not
recommend e-cigarette use as an alternative to smoking.
7. Treatment of pediatric 
venous malformations:
Dilation and ectasias of 
cerebral venous sinuses 
can occur in conditions 
such as Vein of Galen 
malformation and result 
in hydrocephalus, 
cephalomegaly, and 
congestive heart failure. 
Early recognition and 
treatment by transvenous 
obliteration of malformation 
can be life-saving and 
prevent long-term disability.
The applications of 
transvenous approach and 
treatment success rates are 
increasing with new technology. 
As medical professionals, we
must be aware of the indications of transvenous approaches
so we can provide the best options for our patients. 
We recently saw a 21-year-old female with a three-year 
history of idiopathic intracranial hypertension whose
headaches have been refractory to medical therapy.
Previous vision loss responded to lumbar puncture. 
In an 18-month period, she had 19 lumbar punctures with
opening pressures as high as 65 cm H20. We performed
cerebral angiography and venography and she was noted to
have severe left transverse-sigmoid venous sinus stenosis.
Pressure measurements were obtained within the transverse
sinus and subsequently in the sigmoid sinus and a gradient
of 12 mm Hg was demonstrated. At that point, primary
angioplasty was performed with excellent venographic
results. The previously demonstrated pressure gradient 
also normalized. The patient’s headache resolved at 
24 hours and her vision was back to normal.
For more information or a referral to CentraCare Clinic’s
Interventional Neurologists, call 320-240-2829.
Should E-cigarettes be used to help smokers quit?
By Nabeel Ailabouni, DO, Family Medicine, CentraCare Clinic – Big Lake
Figure 2: A lateral venogram
demonstrates an abnormally dilated 
vein behind the ear connecting sigmoid
sinus to external jugular vein (arrows) 
in a patient with tinnitus. 
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Assigning codes based on underlying conditions is not a new
concept of ICD-10, but providers need to better understand
how their documentation of the patients’ illnesses affects
coding. Through education of the coding staff and the
medical staff, we can improve documentation practices by:
• clearly stating manifestations of chronic conditions;
• differentiating between specific conditions 
(i.e. Diabetes Mellitus Type I and Diabetes Mellitus 
Type II. If the latter condition requires insulin, it should 
be noted as Diabetes Mellitus, Type II, insulin requiring) 
(as opposed to insulin dependent);
• showing any existing relationships between hypertensive 
disease, congestive heart failure and renal failure;
• fully documenting exacerbations of COPD;
• identifying the vessel affected as either native or grafted, 
autologous or non-autologous, and/or vein or artery 
graft material used, when a diagnosis of coronary 
atherosclerosis is made;
• indicating the side affected — dominant or 
non-dominant — when hemiplegia occurs following 
a stroke;
• clearly distinguishing between traumatic and 
pathological fractures when diagnosing fractures, 
along with laterality and visit encounter (i.e. initial, 
subsequent or sequel) in addition to if routine healing, 
delayed healing, non-union or malunion or open/closed; 
and 
• clearly documenting complications of medical 
and surgical care.
Consider these two patients. Patient A is a type 2 diabetic
with well-controlled diabetes. Patient B is a type 2 diabetic
with uncontrolled diabetes who also suffers from diabetes-
related chronic kidney disease.
If the provider documents “diabetes mellitus” for both
patients, coders would report the same code, even though
the patients have very different conditions. The provider
loses reimbursement on Patient B, who is sicker and
requires more care.
In today’s busy health care environment, it is important 
to remember that submitted codes will affect future payment
schedules, research databases and public reporting of disease
incidence to name a few. It is very important to document 
to the highest specificity of known condition or disease.
Documentation is the key for appropriate reimbursement
By Connie Goulet, CPC; Sue Stein, CPC; and Jessica Timmer, CPC, Compliance Specialists, 
CentraCare Clinic
